TELUM THERAPEUTICS S.L.
2 Marks
LLC
First Filed:Sep 27, 2021Latest Filed:Sep 27, 2021Address:Plaza Cein, 5 B1, ES
Portfolio Overview
Registered
2(100%)Top Classes
Class 5
PharmaceuticalsClass 42
Software, IT Services & Scientific ResearchClass 1
Industrial Chemicals & AdhesivesTTAB Proceedings
No litigation activity
Top Firms
Tutunjian & Bitetto, P.C.(Sep 2021)
2
Trademark Portfolio
2 results
(current & previous marks)
Refine by Mark/Description🔽
Filed
Registered
Last Activity
Filters
Ownership
2
0
Status
2
0
0
0
0
Mark Type
1
0
0
1
0
1
1
1
1
Goods & Services
Downloadable software for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; downloadable computer software platforms for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; downloadable computer software using artificial intelligence for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; downloadable computer software platforms using artificial intelligence for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria | Software as a service (SaaS) services featuring software for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; software as a service (SaaS) services featuring artificial intelligence software for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; platform as a service (PaaS) services featuring software platforms for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; platform as a service (PaaS) services featuring software platforms using artificial intelligence for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; biomedical research services; scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria; research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; conducting clinical trials for others of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria
Goods & Services
Class 001: Diagnostic preparations for scientific purposes; reagents for medical research use; reagents for medical research in the field of infectious diseases and diseases caused by bacteria; diagnostic reagents for scientific or research use; enzymes for scientific purposes; diagnostic kits comprising specimen receptors being biological tissues cultures and reagents for testing for selected bacteria, other than for medical or veterinary use; Class 005: Pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of diseases caused by bacteria; antibacterial pharmaceuticals; antibiotics; pharmaceutical preparations, namely, biopharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations, namely, immunotherapeutic agents for bacterial infections; enzyme preparations for medical purposes; enzymes for medical purposes; enzymes and enzyme preparations for medical purposes for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; assays, biomarkers and reagents for medical purposes for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; Class 042: Biomedical research services; scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria; research and development of pharmaceutical products, antibiotics, assays, biomarkers and reagents for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; research and development of immunotherapeutic agents for bacterial infections; research and development of enzymes, enzyme preparations and synthetic proteins for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; conducting clinical trials for others of pharmaceutical products, antibiotics, assays, biomarkers and reagents for the diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria